MedPath

Preventive effect of aliskiren on migraine complicated with hypertension.

Not Applicable
Conditions
hypertension migraine
Registration Number
JPRN-UMIN000006350
Lead Sponsor
Department of Neurology, School of Medicine, Keio University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. Individuals taking an ACE inhibitor or ARB. 2. Those who fail to submit informed consent. 3. Those who may be allergic to aliskiren or candesartan. 4. SBP>180 mmHg or DBP>110 mmHg. 5. Those who are pregnant or hope to get pregnant. 6. Menstruation-related migraine patients. 7. Those who are taking cyclosporine. 8. Those who have severe hepatic dysfunction and/or renal dysfunction. 9. Those who are judged not to be eligible for entry to this study by their attending physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath